Avantor
AVTRAvantor is a leading global provider of mission-critical products and services for the biopharma, healthcare, education, and advanced technology sectors.
Earnings
Next report
Date not yet announcedValuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Avantor is a leading global provider of mission-critical products and services for the biopharma, healthcare, education, and advanced technology sectors. The company supports the entire scientific lifecycle from discovery to delivery, embedding its proprietary chemicals and materials into customer research and production workflows. Its value proposition centers on high-purity manufacturing and a massive distribution network that ensures regulatory compliance and operational efficiency for science-driven industries.
Avantor maintains a leading position through its dual-threat model of proprietary high-purity manufacturing and the globally recognized VWR distribution channel.
Questions, answered.
- What is Avantor's market cap?
- Avantor (AVTR) has a market capitalization of $8.5B and trades on NYSE.
- What is Avantor's revenue and profitability?
- Avantor generated $6.6B in trailing twelve-month revenue with a net loss of $630.4M, representing a net margin of -9.6%. Gross margin stands at 31.8%, with free cash flow of $454.7M. These figures are based on the Q2 2026 filing.
- Who are Avantor's competitors?
- Avantor's key competitors include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Avantor have?
- Avantor's subsidiaries include VWR, NuSil, Masterflex, and others.
- Where is Avantor headquartered?
- Avantor is headquartered in United States of America and employs approximately 14,500 people. It has been publicly traded since 2019.
